JP2009537483A5 - - Google Patents

Download PDF

Info

Publication number
JP2009537483A5
JP2009537483A5 JP2009510435A JP2009510435A JP2009537483A5 JP 2009537483 A5 JP2009537483 A5 JP 2009537483A5 JP 2009510435 A JP2009510435 A JP 2009510435A JP 2009510435 A JP2009510435 A JP 2009510435A JP 2009537483 A5 JP2009537483 A5 JP 2009537483A5
Authority
JP
Japan
Prior art keywords
group
alkyl
atom
amino
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009510435A
Other languages
English (en)
Japanese (ja)
Other versions
JP5263686B2 (ja
JP2009537483A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/054631 external-priority patent/WO2007131982A2/de
Publication of JP2009537483A publication Critical patent/JP2009537483A/ja
Publication of JP2009537483A5 publication Critical patent/JP2009537483A5/ja
Application granted granted Critical
Publication of JP5263686B2 publication Critical patent/JP5263686B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009510435A 2006-05-16 2007-05-14 置換プロリンアミド、その製造及び薬物としての使用 Expired - Fee Related JP5263686B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06113977.0 2006-05-16
EP06113977 2006-05-16
EP07102566 2007-02-16
EP07102566.2 2007-02-16
PCT/EP2007/054631 WO2007131982A2 (de) 2006-05-16 2007-05-14 Substituierte prolinamide, deren herstellung und deren verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
JP2009537483A JP2009537483A (ja) 2009-10-29
JP2009537483A5 true JP2009537483A5 (cg-RX-API-DMAC7.html) 2013-05-02
JP5263686B2 JP5263686B2 (ja) 2013-08-14

Family

ID=38646563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009510435A Expired - Fee Related JP5263686B2 (ja) 2006-05-16 2007-05-14 置換プロリンアミド、その製造及び薬物としての使用

Country Status (23)

Country Link
US (1) US7807693B2 (cg-RX-API-DMAC7.html)
EP (1) EP2051975B1 (cg-RX-API-DMAC7.html)
JP (1) JP5263686B2 (cg-RX-API-DMAC7.html)
KR (1) KR101422456B1 (cg-RX-API-DMAC7.html)
AR (1) AR060945A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007251614B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0711648A2 (cg-RX-API-DMAC7.html)
CA (1) CA2653753C (cg-RX-API-DMAC7.html)
CL (1) CL2007001391A1 (cg-RX-API-DMAC7.html)
DK (1) DK2051975T3 (cg-RX-API-DMAC7.html)
EA (1) EA200802210A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP088824A (cg-RX-API-DMAC7.html)
ES (1) ES2395538T3 (cg-RX-API-DMAC7.html)
IL (1) IL195245A (cg-RX-API-DMAC7.html)
MX (1) MX2008014499A (cg-RX-API-DMAC7.html)
MY (1) MY146623A (cg-RX-API-DMAC7.html)
NO (1) NO20084530L (cg-RX-API-DMAC7.html)
NZ (1) NZ573573A (cg-RX-API-DMAC7.html)
PE (1) PE20080702A1 (cg-RX-API-DMAC7.html)
PL (1) PL2051975T3 (cg-RX-API-DMAC7.html)
TW (1) TW200813047A (cg-RX-API-DMAC7.html)
UY (1) UY30352A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007131982A2 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1975165A1 (de) 2007-03-27 2008-10-01 Boehringer Ingelheim Pharma GmbH & Co. KG Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
WO2009063028A2 (en) 2007-11-15 2009-05-22 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
US20110046130A1 (en) * 2008-03-31 2011-02-24 Evotec Ag Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
GB201209138D0 (en) * 2012-05-24 2012-07-04 Ono Pharmaceutical Co Compounds
EP2958919B1 (en) 2013-02-21 2019-05-22 Boehringer Ingelheim International GmbH Dihydropteridinones i
JP6337750B2 (ja) * 2013-11-22 2018-06-06 小野薬品工業株式会社 化合物
DK3102576T3 (da) 2014-02-03 2019-07-22 Vitae Pharmaceuticals Llc Dihydropyrrolopyridininhibitorer af ror-gamma
HRP20221373T1 (hr) * 2014-03-07 2023-01-06 Biocryst Pharmaceuticals, Inc. Supstituirani pirazoli kao inhibitori kalikreina u ljudskoj plazmi
SI3207043T1 (sl) 2014-10-14 2019-04-30 Vitae Pharmaceuticals, Inc. Dihidropirolopiridinovi inhibitorji za ROR-gama
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
EP3078378B1 (en) 2015-04-08 2020-06-24 Vaiomer Use of factor xa inhibitors for regulating glycemia
EP3331876B1 (en) 2015-08-05 2020-10-07 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
EP3868750A1 (en) 2015-11-20 2021-08-25 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ROR-γ調節劑
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
CN115716826A (zh) 2017-07-24 2023-02-28 生命医药有限责任公司 RORγ的抑制剂
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
CN114646701B (zh) * 2022-03-01 2023-09-29 浙江国邦药业有限公司 一种l-脯氨酰胺中有关物质的hplc测试方法
CN121311466A (zh) * 2023-04-14 2026-01-09 辉瑞大药厂 葡萄糖依赖性促胰岛素多肽受体拮抗剂及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030141B2 (en) 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
JP3975254B2 (ja) * 2002-07-25 2007-09-12 日野自動車株式会社 チャイルドシート用アンカの取付構造
PL377633A1 (pl) 2003-04-03 2006-02-06 Merck Patent Gmbh Związki karbonylowe
DE10329457A1 (de) * 2003-04-03 2005-01-20 Merck Patent Gmbh Ethinylprolinderivate
US7557222B2 (en) * 2003-06-18 2009-07-07 Merck Patent Gmbh 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis
ES2223277B1 (es) 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
DE10358814A1 (de) * 2003-12-16 2005-07-21 Merck Patent Gmbh Prolinylarylacetamide
DE102004014945A1 (de) 2004-03-26 2005-10-13 Merck Patent Gmbh Prolinylderivate
US7453002B2 (en) * 2004-06-15 2008-11-18 Bristol-Myers Squibb Company Five-membered heterocycles useful as serine protease inhibitors
DE102004045796A1 (de) 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
EP1869010A1 (en) 2005-04-11 2007-12-26 Glaxo Group Limited 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors
AU2006271781A1 (en) * 2005-07-15 2007-01-25 F. Hoffmann-La Roche Ag Novel heteroaryl fused cyclic amines

Similar Documents

Publication Publication Date Title
JP2010522713A5 (cg-RX-API-DMAC7.html)
RU2483072C2 (ru) Производные фосфоновой кислоты и их применение в качестве антагонистов рецептора p2y12
NO20063340L (no) Pyrazol-[3,4-B]-pyridinforbindelser, og deres anvendelse som fosfodiesteraseinhibitorer
JP2011515483A5 (cg-RX-API-DMAC7.html)
DK2864318T3 (en) 2-AMINOPYRAZINE DERIVATIVES AS CSF-1R KINase INHIBITORS
CY1106857T1 (el) Βενζαμιδια 4-(αμινομεθυλ)-πιπεριδινης ως 5ht4-ανταγωνιστες
RU2010137115A (ru) Производные 5,6-бисарил-2-пиридинкарбоксамидов, способ их получения и их применение в терапии в качестве антагонистов рецепторов
RU2007129090A (ru) Органические соединения
ATE418548T1 (de) Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
JP2005513065A5 (cg-RX-API-DMAC7.html)
RU2008136754A (ru) Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств
AR037350A1 (es) Derivados de piperidina, proceso para preparar estos compuestos, composicion farmaceutica, y uso de estos compuestos para la manufactura de un medicamento util para el tratamiento de una enfermedad mediada por ccr5 (tal como artritis reumatoidea)
JP2004530691A5 (cg-RX-API-DMAC7.html)
JPWO2015056771A1 (ja) 含硫黄二環式化合物
HRP20110044T2 (hr) Supstituirani glicinamidi s antitrombotičkim i faktor-xa inhibirajućim djelovanjem
WO2004041806A3 (en) Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists
JP2008525400A5 (cg-RX-API-DMAC7.html)
JP2018503647A5 (cg-RX-API-DMAC7.html)
PE20242216A1 (es) Compuestos de heteroaril-urea novedosos como inhibidores de kv7.2
NO20065327L (no) Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid.
EA200701035A1 (ru) Замещенные n-сульфониламинобензил-2-феноксиацетамидные соединения
RU2007144525A (ru) 3-моно- и 3,5-дизамещенные пиперидиновые производные в качестве ингибиторов ренина
RU2427575C2 (ru) Амидные производные
JP2007528884A5 (cg-RX-API-DMAC7.html)
AR054072A1 (es) 3-amino arilpropil indoles como inhibidores de reabsorcion de monoaminas. procesos de obtencion y composiciones farmaceuticas